source
- Cellares signs first Asian manufacturing deal with Taiwan's GenomeFrontier Therapeutics for CAR-T productionCellares announced a new partnership with Taiwanese biotech GenomeFrontier Therapeutics, marking the manufacturer’s first collaboration in Asia. The agreement will see Cellares evaluate and potenti…
- Webinar Explores Manufacturing Risks and Partner Strategies for the Next Five YearsThe webinar titled "Manufacturing in Turbulent Times" is scheduled for September 17, 2026 and is designed to help biopharma sponsors understand the manufacturing challenges that lie ahead. It note…